New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Jump To Section
Featured Stories



Spotlight On 2021
2021 Could Be Start Of Global Beauty Microplastic Purge
The European Union’s deliberations in 2021 on a proposed microplastic restriction will determine exactly what and when microplastic ingredients must be removed from cosmetic products on the EU market, likely with global ripple effects.
NGOs To Assert COVID-Unsafe Cosmetic Ingredients In Next US Legislative Reform Push
New Year, Same Sanitizer, COVID-19 Warnings In US; FDA Says Herbal Firm’s ‘Tags’ Are Drug Claims
OTC Sanitizers Lather Up US Drug Recalls In 2020
US Cosmetics Reform Talks To Resume In 2021 After COVID Derailing, Anti-Regulation Trump
Latest From HBW Insight
OUTLOOK 2021
In Vivo’s annual showcase of special features and industry league tables for pharma, medtech and generics companies
VIEW 2021 RANKINGS
Health Explore this Topic
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health
Health And Wellness Trademark Review 23 February, 2021
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
CA Tries Again To Age-Restrict Workout Supplement Sales, MA On Energy Drinks
Massachusetts legislation proposes age-restricting energy drink sales and says violating parties will face fines between $50 and $250. California bill would prohibit sales of weight loss and workout products to minors, as is already proposed in New York and Massachusetts.
US FDA’s 30-Day Extension For Nitrosamine Assessments Short Of Industry Recommendation
Revision to FDA's September 2020 guidance on assessing nitrosamine impurity risks associated with all chemically synthesized APIs and all approved drug products that contain those APIs doesn’t satisfy industry stakeholders.
RB Doubles R&D Spend In Search Of 'Game Changing’ OTC Innovation
With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.
Australia’s Starpharma Plans To Launch COVID-Killing Nasal Spray In Europe
Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?
With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’
Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.
Beauty Explore this Topic
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Beauty
‘The Dark Side’ Of Green Packaging: Cosmetics Technical Expert On Challenges And Potential Risks
Presenting at the Independent Beauty Association’s Cosmetic Technical/Regulatory Forum, Product Integrity Laboratory’s Howard Baker dug into the less-discussed aspects of green packaging that “could damage your brand’s reputation, cause regulatory and legal problems, and severely harm the economics of your business.”
Cosmetic And Personal Care Trademark Review 23 February, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
CIR ‘Watchdog’ Women’s Voices For The Earth To Remain On Guard In 2021
NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.
Estee Lauder Companies To Make ‘Abnormal Beauty’ Its Own
The beauty titan will increase its stake in DECIEM to 76% in a deal valuating The Ordinary skin-care owner at $2.2bn. Remaining interests will be acquired after three years, according to the announcement.
IFF Plus DuPont N&B Equals $11.2Bn Revenues
"Now it's up to us to look where can we accelerate our portfolio, in which areas and where can we grow the most and deliver good value for our customers,” says CEO Andreas Fibig.
‘Uniquely Positioned’ In Probiotics, IFF Emphasizes Ingredients For Women's, Cognitive, Skin Health
Jennifer Montgomery, IFF’s probiotics marketing manager for the Americas, responds to HBW Insight questions about the firm’s plans to deliver probiotics ingredients and technologies following the recent closing of its acquisition of DuPont Nutrition & Biosciences through a merger agreement.
Wellness Explore this Topic
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Wellness
Health And Wellness Trademark Review 23 February, 2021
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
RB Doubles R&D Spend In Search Of 'Game Changing’ OTC Innovation
With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.
With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’
Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.
Bausch Shines Planned Spin-Out, Launches First US Preservative-Free OTC Antihistamine Eye Drops
Bausch + Lomb’s Alaway Preservative-Free antihistamine eye drops launch in US, The Bausch Health Companies division planned as spin-out also recently gained South Korean approval for its Lumify OTC redness reliever drops and has submissions under review in other countries.
IFF Plus DuPont N&B Equals $11.2Bn Revenues
"Now it's up to us to look where can we accelerate our portfolio, in which areas and where can we grow the most and deliver good value for our customers,” says CEO Andreas Fibig.
‘Uniquely Positioned’ In Probiotics, IFF Emphasizes Ingredients For Women's, Cognitive, Skin Health
Jennifer Montgomery, IFF’s probiotics marketing manager for the Americas, responds to HBW Insight questions about the firm’s plans to deliver probiotics ingredients and technologies following the recent closing of its acquisition of DuPont Nutrition & Biosciences through a merger agreement.
Market Intelligence Explore this Topic
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Market Intelligence
Health And Wellness Trademark Review 23 February, 2021
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Cosmetic And Personal Care Trademark Review 23 February, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
US OTC Market In 2020: COVID-19 Impact Obvious In Medical Device As Well As Drug Sales Growth
Most notably among OTC drugs, hand sanitizer sales were up more than 600% to $1.46bn, while sales of consumer medical devices grew 15.6% to $14.8bn in 2020, according to CHPA report.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.